Impact of sarcopenia defined by carina-level skeletal muscle mass on the long-term prognosis of patients with idiopathic pulmonary fibrosis
Background Sarcopenia, defined using abdominal computed tomography (CT), has been
used as a prognostic marker for patients with idiopathic pulmonary fibrosis (IPF). However …
used as a prognostic marker for patients with idiopathic pulmonary fibrosis (IPF). However …
Thoracic skeletal muscle quantification: low muscle mass is related with worse prognosis in idiopathic pulmonary fibrosis patients
Background Sarcopenia can contribute to negative outcomes in patients with various lung
diseases. However, whether sarcopenia affects prognosis in patients with idiopathic …
diseases. However, whether sarcopenia affects prognosis in patients with idiopathic …
[HTML][HTML] Prevalence and risk factors of sarcopenia in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
J Li, Y Lu, M Deng, R Tong, Q Zhang, Y Bian… - Frontiers in …, 2023 - frontiersin.org
Background Sarcopenia often occurs as a comorbidity in many diseases which ultimately
affects patient prognosis. However, it has received little attention in patients with idiopathic …
affects patient prognosis. However, it has received little attention in patients with idiopathic …
Frequency and impact on clinical outcomes of sarcopenia in patients with idiopathic pulmonary fibrosis
K Fujita, H Ohkubo, A Nakano, Y Mori… - Chronic Respiratory …, 2022 - journals.sagepub.com
Objectives Sarcopenia is a syndrome characterized by reduced muscle mass and function. It
is well-recognized as a complication in chronic diseases such as chronic obstructive …
is well-recognized as a complication in chronic diseases such as chronic obstructive …
Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy
Y Suzuki, Y Aono, M Kono, H Hasegawa… - …, 2021 - Wiley Online Library
Background and objective Recent research has highlighted the fundamental role of
sarcopenia, characterized by loss of skeletal muscle mass and strength, with a risk of poor …
sarcopenia, characterized by loss of skeletal muscle mass and strength, with a risk of poor …
Sarcopenia in idiopathic pulmonary fibrosis: a prospective study exploring prevalence, associated factors and diagnostic approach
P Faverio, A Fumagalli, S Conti, F Madotto, F Bini… - Respiratory …, 2022 - Springer
Background Sarcopenia gained importance in the evaluation of patients with chronic
respiratory diseases, including idiopathic pulmonary fibrosis (IPF), since it may impact …
respiratory diseases, including idiopathic pulmonary fibrosis (IPF), since it may impact …
Quantitative computed tomography measures of skeletal muscle mass in patients with idiopathic pulmonary fibrosis according to a multidisciplinary discussion …
N Awano, M Inomata, N Kuse, M Tone… - Respiratory …, 2020 - Elsevier
Background Idiopathic pulmonary fibrosis (IPF) is a progressive disease often accompanied
by skeletal muscle wasting. We investigated whether skeletal muscle mass and muscle …
by skeletal muscle wasting. We investigated whether skeletal muscle mass and muscle …
Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis
K Fujita, H Ohkubo, A Nakano, N Takeda… - BMC pulmonary …, 2022 - Springer
Background The serum creatinine/cystatin C (Cr/CysC) ratio has attracted attention as a
marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary …
marker for sarcopenia, but has not been studied in patients with idiopathic pulmonary …
[PDF][PDF] Association of musculoskeletal involvement with lung function and mortality in patients with idiopathic pulmonary fibrosis
M Sridhar, S Bodduluri, L O'Hare, S Blumhoff… - Respiratory …, 2024 - Springer
Idiopathic pulmonary fibrosis (IPF) is a progressive disease associated with high mortality.
Low muscle mass, frailty and sarcopenia lead to functional impairment that negatively …
Low muscle mass, frailty and sarcopenia lead to functional impairment that negatively …
Decreased peak expiratory flow rate associated with mortality in idiopathic pulmonary fibrosis: A preliminary report
K Fujita, H Ohkubo, A Nakano… - Chronic Respiratory …, 2022 - journals.sagepub.com
Objectives The peak expiratory flow rate (PEFR) is known to decrease in patients with
sarcopenia. However, little is known about the clinical impact of the PEFR in idiopathic …
sarcopenia. However, little is known about the clinical impact of the PEFR in idiopathic …
相关搜索
- muscle mass impact of sarcopenia
- muscle mass fibrosis patients
- sarcopenia in patients frequency and impact
- sarcopenia in patients cause of mortality
- muscle mass tomography measures
- sarcopenia in patients surrogate marker
- sarcopenia in patients antifibrotic therapy
- muscle mass discussion diagnosis
- muscle mass physical performance
- sarcopenia in patients clinical outcomes
- muscle quantification fibrosis patients